| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/19/2011 | US20110118343 Antitumoral Macrolides |
| 05/19/2011 | US20110118342 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 05/19/2011 | US20110118341 Long term disease modification using immunostimulatory oligonucleotides |
| 05/19/2011 | US20110118340 Delivery of rnai constructs to oligodendrocytes |
| 05/19/2011 | US20110118339 Chemically modified oligonucleotides and uses thereof |
| 05/19/2011 | US20110118338 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 05/19/2011 | US20110118337 Method of Using Compositions Comprising MIR-192 and/or MIR-215 for the Treatment of Cancer |
| 05/19/2011 | US20110118336 Microrna-21 antagonists and its target PDCD4 for use in the treatment of a glioma |
| 05/19/2011 | US20110118335 RNA Interference Mediated Inhibition Of Gene Expression Using Multifunctional Short Interfering Nucleic Acid (Multifunctional siNA) |
| 05/19/2011 | US20110118334 Antisense antiviral compound and method for treating influenza viral infection |
| 05/19/2011 | US20110118332 Viral microrna |
| 05/19/2011 | US20110118331 Cationic sirnas, synthesis and use for rna interference |
| 05/19/2011 | US20110118330 Hiv protease inhibitors and methods for using |
| 05/19/2011 | US20110118329 Uses of ion channel modulating compounds |
| 05/19/2011 | US20110118328 Novel crystalline forms |
| 05/19/2011 | US20110118327 In vivo assessment of toxicity and pharmacokinetics of methylglyoxal |
| 05/19/2011 | US20110118326 Androgen Receptor Modulator and Uses Thereof |
| 05/19/2011 | US20110118325 Rel inhibitors and methods of use thereof |
| 05/19/2011 | US20110118324 Method and composition for treating multiple sclerosis (variants) |
| 05/19/2011 | US20110118323 Macrocyclic compounds and methods of treatment |
| 05/19/2011 | US20110118322 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators |
| 05/19/2011 | US20110118321 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 05/19/2011 | US20110118320 Substituted pyrroles and methods of use |
| 05/19/2011 | US20110118318 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 05/19/2011 | US20110118317 Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism |
| 05/19/2011 | US20110118316 Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection |
| 05/19/2011 | US20110118315 5-lipoxygenase-activating protein (flap) inhibitors |
| 05/19/2011 | US20110118314 Piperidine analogs as glycogen synthase activators |
| 05/19/2011 | US20110118313 Identification of a molecular signature for antipsychotics and serms |
| 05/19/2011 | US20110118312 Benzylpiperizine compound |
| 05/19/2011 | US20110118311 Azole compound |
| 05/19/2011 | US20110118310 Treatment Using D-Threo Methylphenidate |
| 05/19/2011 | US20110118309 Use of hdac inhibitors for the treatment of hodgkin's disease |
| 05/19/2011 | US20110118308 Crystals of laquinimod sodium, and process for the manufacture thereof |
| 05/19/2011 | US20110118307 Compositions and methods for the treatment of infectious diseases |
| 05/19/2011 | US20110118306 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 05/19/2011 | US20110118305 Compounds |
| 05/19/2011 | US20110118304 Method for treating over-eating disorders |
| 05/19/2011 | US20110118303 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these |
| 05/19/2011 | US20110118302 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| 05/19/2011 | US20110118301 Amino-Aza-Adamantane Derivatives and Methods of Use |
| 05/19/2011 | US20110118300 Glucose metabolism modulating compounds |
| 05/19/2011 | US20110118299 Treatment of mci and alzheimer's disease |
| 05/19/2011 | US20110118298 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer |
| 05/19/2011 | US20110118297 Tivozanib and Temsirolimus in Combination |
| 05/19/2011 | US20110118296 Bis-Carbazole DNA Intercalating Agents for Antitumor Therapy |
| 05/19/2011 | US20110118295 Methods for treating bowel diseases |
| 05/19/2011 | US20110118294 Intranasal Opioid Compositions |
| 05/19/2011 | US20110118293 Method of restoring the incretin effect |
| 05/19/2011 | US20110118292 Method of treating atherosclerosis, dyslipidemias and related conditions |
| 05/19/2011 | US20110118291 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
| 05/19/2011 | US20110118289 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands |
| 05/19/2011 | US20110118288 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 05/19/2011 | US20110118287 Bicycloheteroaryl Compounds As P2X7 Modulators and Uses Thereof |
| 05/19/2011 | US20110118286 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 05/19/2011 | US20110118285 Heterocycles as protein kinase inhibitors |
| 05/19/2011 | US20110118284 Thienopyrimidine compounds |
| 05/19/2011 | US20110118283 Substituted Pyrrolidine-2-Carboxamides |
| 05/19/2011 | US20110118282 Soluble Guanylate Cyclase Activators |
| 05/19/2011 | US20110118281 Compounds for inflammation and immune-related uses |
| 05/19/2011 | US20110118280 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/19/2011 | US20110118279 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors |
| 05/19/2011 | US20110118278 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs |
| 05/19/2011 | US20110118277 Method of treating liver disease |
| 05/19/2011 | US20110118276 Methods of treating atherosclerosis |
| 05/19/2011 | US20110118275 OXAZOLO[4,5-c]PYRIDINE SUBSTITUTED PYRAZINE |
| 05/19/2011 | US20110118274 Proteasome inhibitors and their use in treating pathogen infection and cancer |
| 05/19/2011 | US20110118273 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| 05/19/2011 | US20110118272 Spectinamides as anti-tuberculosis agents |
| 05/19/2011 | US20110118271 Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases |
| 05/19/2011 | US20110118270 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 05/19/2011 | US20110118269 Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases |
| 05/19/2011 | US20110118268 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators |
| 05/19/2011 | US20110118267 Method and Kit for Treating or Preventing Psoriasis |
| 05/19/2011 | US20110118266 Derivatives of triazines and uracils, their preparation and their application in human therapeutics |
| 05/19/2011 | US20110118265 Use of anti-bacterial agents for the treatment of epithelial-related conditions |
| 05/19/2011 | US20110118264 Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof |
| 05/19/2011 | US20110118263 Benzothiophene alkanol piperazine derivatives and their use as antidepressant |
| 05/19/2011 | US20110118262 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors |
| 05/19/2011 | US20110118261 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 05/19/2011 | US20110118260 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group |
| 05/19/2011 | US20110118259 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 05/19/2011 | US20110118258 Quinazolin-oxime derivatives as hsp90 inhibitors |
| 05/19/2011 | US20110118257 Novel kinase modulators |
| 05/19/2011 | US20110118256 Imidazo [1,2-a] pyridin-3-yl-acetic acid hydrazides, processes, uses and compositions |
| 05/19/2011 | US20110118255 PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JAK2 INHIBITORS |
| 05/19/2011 | US20110118254 Therapeutic agent for inflammatory bowel disease |
| 05/19/2011 | US20110118253 5-methyl-1-(naphthalen-2-yl)-1h-pyrazoles useful as sigma receptor inhibitors |
| 05/19/2011 | US20110118252 Substituted amide derivatives and methods of use |
| 05/19/2011 | US20110118251 Spiropiperidine compounds as orl-1 receptor antagonists |
| 05/19/2011 | US20110118250 Beta-secretase modulators and methods of use |
| 05/19/2011 | US20110118249 Inhibitors of human immunodeficiency virus replication |
| 05/19/2011 | US20110118248 Heteroaryl sulfonamides and CCR2/CCR9 |
| 05/19/2011 | US20110118247 2-Methyl-5-Imino-Benzo[D][1,3]Oxazin[5-B]Pyrazole Compound, Preparation and Use Thereof |
| 05/19/2011 | US20110118246 Novel Compounds |
| 05/19/2011 | US20110118245 Raf kinase modulator compounds and methods of use thereof |
| 05/19/2011 | US20110118244 Factor xa inhibitors |
| 05/19/2011 | US20110118243 Anti-inflammatory drug delivery system |
| 05/19/2011 | US20110118242 3,7-diamino-10h-phinothiazine salts and their use |
| 05/19/2011 | US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2 |